A state variable is a coordinate used to describe the instantaneous condition of a dynamical system sufficiently completely to determine its future evolution under a specified model and input. For a simple pendulum, its angle and angular velocity form a state; angle alone generally does not, because the same position can be traversed in either direction.

A second-order ordinary differential equation $\ddot{q}=f(q,\dot{q},t)$ becomes a first-order system by setting $v=\dot{q}$: $\dot{q}=v$ and $\dot{v}=f(q,v,t)$. The choice of state variables therefore reflects the memory required by the model, and differs from merely listing measured outputs.

Synchronization of oscillators occurs when interacting or driven oscillators acquire a sustained relation between their phases or frequencies. Equal amplitudes are not required. In one simple phase model, a relative phase $\psi$ obeys $\dot{\psi }=\Delta \omega -K\sin \psi$, where $\Delta \omega$ is the uncoupled frequency mismatch and $K>0$ the coupling strength.

When $|\Delta \omega |<K$, a fixed relative phase exists; the branch with $\cos \psi >0$ is stable because the linearized restoring coefficient is $-K\cos \psi$. The Kuramoto model extends this competition between mismatch and coupling to a population of phase oscillators.^[ref]

An additive cocycle over a dynamical system records a quantity accumulated along a flow. It satisfies $c(0,x)=0$ and $c(s+t,x)=c(t,x)+c(s,{\Phi }_{t}x)$: accumulation over two intervals equals accumulation over the first interval plus accumulation over the second interval from the evolved state.

For an dynamical observable $h$, the integral $c(t,x)={\int }_0^{t}h({\Phi }_{u}x)du$ is an example, as splitting the integral at $t$ proves the identity. A coboundary has the special form $c(t,x)=u({\Phi }_{t}x)-u(x)$. Matrix-valued multiplicative versions replace addition by an ordered product; the order matters when the matrices do not commute.

A time average measures an dynamical observable along a single trajectory of a dynamical system. For a flow ${\Phi }_t$, define $A_{T}h(x)=T^{-1}{\int }_0^{T}h({\Phi }_{t}x)dt$. If the limit as $T\to \infty$ exists, it is the long-time average at initial state $x$. For a discrete map $T$, the corresponding expression is $n^{-1}{\sum }_{j=0}^{n-1}h(T^{j}x)$.

If $h({\Phi }_{t}x)=\cos t$, the average tends to zero although the observable never settles to a constant. The Birkhoff ergodic theorem supplies almost-everywhere existence for integrable observables under a probability-preserving map. Equality with a spatial average requires the appropriate ergodicity assumption; existence alone does not imply it.

For a map $T:X\to X$ and a given dynamical observable $f$, the additive cohomological equation asks for a function $u$ satisfyingWhen such $u$ exists, $f$ is a difference accumulated between consecutive states. Summing along a trajectory makes the intermediate terms cancel:Thus bounded $u$ forces these sums to remain bounded, and any periodic orbit of period $n$ must have sum zero. These are necessary conditions, not a universal existence theorem.

For the circle rotation $T(x)=x+\alpha (\mathrm{mod}1)$, try $f(x)=e^{2\pi ikx}$ and $u(x)=c{e}^{2\pi ikx}$. Then $c=(e^{2\pi ik\alpha }-1{)}^{-1}$ when the denominator is nonzero. If it vanishes, this mode is an obstruction; if it is very small, the coefficient is large. This explains how a simple equation leads to delicate regularity questions in dynamical systems.

A dynamical observable is a function $\phi :X\to \mathbb{R}$ or $\mathbb{C}$ that assigns a measurable quantity to each state of a dynamical system. If the dynamics is $T:X\to X$, the observed sequence from state $x$ is $\phi (x),\phi (Tx),\phi (T^{2}x),\dots$. The state space may be high dimensional even when this record is scalar.

For a harmonic oscillator with state $(q,p)$, position $\phi (q,p)=q$ is one dynamical observable; energy is another. Position generally oscillates, while energy is constant along an ideal conservative trajectory. Composition $\phi \mapsto \phi \circ T$ describes evolution of the measured quantity instead of evolution of states. Its time average, $n^{-1}{\sum }_{j=0}^{n-1}\phi (T^{j}x)$, is the object compared with a space integral in ergodic theory.

Duck typing uses an object's available operations as the practical interface required by a piece of code, rather than demanding membership in one particular class. The Python glossary describes calling the needed method or using the needed attribute directly. This supports flexible reuse across unrelated implementations.^[ref]

For example, a procedure calling source.read() can accept a disk-backed file object or an in-memory object providing a compatible read method. Sharing that method name is insufficient if one method returns text while the procedure requires bytes, or if their error behavior differs. The required interface includes semantics as well as names. Duck typing is commonly used with dynamic typing, but it does not imply that missing or incompatible operations become valid.

A Bellman operator maps a proposed value function to the value obtained by one optimal decision followed by that proposed continuation value. For a finite discounted Markov decision process with bounded reward $r$, transition probabilities $P$, discount $0\le \gamma <1$ and nonempty finite action sets,The optimal value function satisfies the Bellman equation $V^{\ast }=T{V}^{\ast }$. The cost-minimization convention replaces the maximum by a minimum.

For any $V,W$, the difference between the two maxima is bounded by the maximum difference of their terms, so $\Vert TV-TW{\Vert }_{\infty }\le \gamma \Vert V-W{\Vert }_{\infty }$. The Banach fixed-point theorem gives a unique fixed point and convergence of value iteration in this finite setting. In a single state with reward two and discount one-half, $TV=2+V/2$, hence $V^{\ast }=4$. Undiscounted problems require different conditions; the same contraction argument does not apply at $\gamma =1$.

A drug release rate is the amount released from a formulation per unit time. If $M_{\mathrm{rel}}(t)$ is cumulative released amount, the instantaneous rate isIts units are amount per time, such as mass per hour. Dividing by a reference amount gives a fractional rate; dividing by release area gives a mass flux. These normalizations answer different questions and should be stated explicitly.

In discrete measurements, one commonly obtains an interval mean:For illustrative cumulative amounts $0$, $2$ and $3\mathrm{mg}$ at zero, one and three hours, the interval means are $2$ and $0.5\mathrm{mg}{\mathrm{h}}^{-1}$. The second value is an average over two hours, not necessarily the instantaneous rate at their midpoint. A decreasing rate can coexist with a cumulative amount that continues to increase.

Differentiation also amplifies measurement noise. With times treated as exact, propagation of uncertainty givesFor independent amount errors with standard deviation $0.10\mathrm{mg}$ each, a one-hour interval gives rate standard deviation about $0.141\mathrm{mg}{\mathrm{h}}^{-1}$; shortening the interval to $0.10\mathrm{h}$ raises it to about $1.41\mathrm{mg}{\mathrm{h}}^{-1}$. Repeated-sampling corrections can introduce shared errors, so independence must not be assumed automatically.

An in vitro drug release test measures release through an apparatus, and the separation step can influence the rate observed.^[ref] Reporting the amount definition, normalization, time interval, sampling correction in drug release testing and uncertainty makes a rate estimate interpretable. A smoother fitted derivative can be useful, but it also introduces assumptions about the curve between observations.

Diffusion-controlled drug release occurs when molecular transport down a concentration gradient controls the relevant release time scale. It is a mechanism defined for a particular material, geometry and environment, rather than a name for every slowly changing release curve. A classic theoretical treatment by T. Higuchi distinguishes several matrix and geometrical models.^[ref]

A simple example is an initially uniform dissolved substance of concentration $c_0$ in a planar material, with constant diffusion coefficient $D$. At early times, approximate the material as the half-space $x>0$ and impose a perfect sink condition in drug release, $c(0,t)=0$. Solving the diffusion equation givesFick's first law then gives outward mass flux of magnitudeThis derivation is for dissolved material under the stated boundary condition; it does not identify every square-root law with the same solid-particle matrix model.

For a finite layer of thickness $L$ releasing through one face, the early-time fraction is approximately $F=2\sqrt{Dt/\pi }/L$. With illustrative $L=0.10\mathrm{mm}$ and $D=10^{-12}{\mathrm{m}}^2{\mathrm{s}}^{-1}$, the time scale $L^2/D$ is $10^4\mathrm{s}$, and at $100\mathrm{s}$ the approximation gives $F\approx 0.113$. Extending it to $10^4\mathrm{s}$ would give $F>1$, demonstrating its failure once the finite size matters. The initial mathematical singularity in $J(t)$ likewise reflects idealized initial and boundary conditions.

A useful experimental check changes thickness while keeping material and boundary conditions comparable: this diffusion model predicts a time scale proportional to $L^2$. Swelling, changing diffusivity, degradation or external transport can alter that scaling. A membrane used by the measurement apparatus can also limit transport, so observing a slow curve alone does not locate the controlling resistance inside the formulation.^[ref]

Etanercept is a recombinant soluble fusion protein that binds tumor necrosis factor and reduces its availability to cell-surface receptors. It combines the extracellular ligand-binding portion of the p75 tumor necrosis factor receptor 2 with an Fc region from human immunoglobulin, forming a dimeric protein. The receptor-derived binding portion distinguishes this design from an antibody whose antigen recognition is provided by variable domains.^[ref]

The molecular idea is interception of a signaling ligand before it engages its usual surface receptor. The primary label describes inhibition of TNF binding to cell-surface receptors. Binding, cellular neutralization and a clinical outcome remain different observations; one should not substitute an isolated binding measurement for all downstream effects.^[ref]

A motivating assay measures protection against TNF-dependent loss of cell viability. The official USP bioassay note identifies a neutralization assay using the L929 cell line, a murine fibroblast system, with a cell-viability readout. Reference and test materials are compared under a specified assay model, including checks on curve comparability.^[ref]

An original normalized-readout example has viability signal $V_{\mathrm{TNF}}=0.20$ with the challenge and $V_0=1.00$ without it. If a test condition gives $V=0.60$, define fractional rescue asThis is half of the assay’s recoverable signal range, not a $50\%$ probability of a patient benefit. Baseline changes, altered cell condition or readout interference can change the apparent rescue.

The example connects etanercept to graded dose response, reference-standard bioassays and measurement controls. An assay-specific midpoint or relative potency describes a tested response under defined conditions; it is not a treatment regimen or a universal measure of efficacy.

A nuisance function is an unknown function needed to identify or estimate a target statistical parameter but not itself the primary estimand. In treatment-effect estimation, examples are the propensity score $e(x)=\mathbb{P}(A=1\mid X=x)$ and the outcome-regression functions $m_a(x)=\mathbb{E}[Y\mid A=a,X=x]$.

These functions can be infinite-dimensional even when the target is one number. Estimating them poorly can bias that target, so nuisance does not mean irrelevant. Doubly robust estimation and Neyman orthogonality control certain nuisance errors, while cross-fitting separates training observations from score evaluation. None of these devices removes the identification assumptions needed to interpret an observational treatment comparison causally.^[ref]

A carbon-carbon double bond is a covalent bond of bond order two between carbon atoms, conventionally written $\mathrm{C}=\mathrm{C}$. In a localized orbital description it consists of one sigma bond and one pi bond. The distinction describes the symmetry of the bonding orbitals: the localized pi interaction has a nodal plane containing the internuclear axis, whereas the sigma interaction does not.^[ref]

Ethylene, ${\mathrm{H}}_2\mathrm{C}=\mathrm{C}{\mathrm{H}}_2$, illustrates the counting. Its four carbon–hydrogen connections are sigma bonds, and the carbon–carbon connection contributes another sigma bond plus one pi bond. The localized picture therefore has five sigma bonds and one pi bond, representing six shared electron pairs. Calling the central connection a double bond does not mean that the two bonding interactions are geometrically identical.

Maintaining the pi bond favors an aligned arrangement of the participating orbitals. Rotation that destroys this overlap has an energetic cost, which helps make cis-trans isomerism meaningful when each double-bonded carbon has suitable distinct substituents. Ethylene itself has identical hydrogens at each end, so it does not furnish that geometric distinction.

Chemical reactions can change the connection while retaining the carbon skeleton. Fumarate hydratase adds water across the carbon-carbon double bond of fumarate to produce L-malate; the reverse reaction removes water and restores the double bond.^[ref] Counting atoms and identifying bond order thus reveal different parts of the transformation.